To include your compound in the COVID-19 Resource Center, submit it here.

AZN beats Street EPS estimate

AstraZeneca (LSE:AZN; AZN) reported third quarter EPS of $0.47, which beat by $0.12 the Street's $0.35 estimate and

Read the full 181 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE